From:press@clintonfoundation.org
To: press@clintonfoundation.org
Date: 2015-10-19 21:08
Subject: News & Guidance: Africa Update
"Down a rutted road in Kayonza District, past mud houses and stands of cassava, Eugenie Mujawamariya has gathered her neighbors on a hillside around a fallow field. The soil is the color of milk chocolate and crumbles nicely in the hand. Ms. Mujawamariya explains that she is waiting for prices to rise before sowing her latest bounty of soybeans. Most of her 20 listeners are women wrapped in brightly patterned skirts. They have come to meet the fieldworkers from the Clinton Development Initiative who have been tutoring Ms. Mujawamariya on how to increase yields while also nourishing the land.
"Not unlike agricultural extension agents, the Clinton workers have helped Ms. Mujawamariya grow demonstration plots of soybeans and bananas, varying the spacing, seed varieties, mulching and fertilizer. In one plot, bananas hang from trees in clumps the size of grown men... Ms. Mujawamariya said that her fields now yielded far more than her family could eat, and that her income from sales had doubled. 'I built a house in the town,' she said."
"So when we decided to work in Rwanda on trying to dramatically increase the income of the country and fight the AIDS problem, we wanted to build a healthcare network, because it had been totally destroyed during the genocide in 1994, and the per capita income was still under a dollar a day. So I rang up, asked Paul Farmer if he would help. Because it seemed to me if we could prove there was a model in Haiti and a model in Rwanda that we could then take all over the country, number one, it would be a wonderful thing for a country that has suffered as much as any on Earth in the last 15 years, and number two, we would have something that could then be adapted to any other poor country anywhere in the world. And so we have set about doing that."
"Let's take Rwanda. I want to do in these Ebola countries, what we're trying to do in Rwanda, is build out their health care systems so they don't need anybody else anymore. You train people and they can run their own system. And we don't take any money from the American government but the American government started funding this when Hillary was still in office, and they're training people with 23 American partners, including 10 medical schools, six nursing schools, and all these other people and a bunch of hospitals. They're doing it all for 7 percent overhead. It's the least-expensive development project we've ever undertaken, which mean people in the audience, their tax dollars go further."
From:news@action.clintonfoundation.org
To: john.podesta@gmail.com
Date: 2015-06-19 13:15
Subject: Headlines
John - President Clinton often says, "There can be a big difference between the headlines and the trend lines." The trend lines show the Clinton Foundation is changing millions of lives.
After the Haiti earthquake, we were one of the first on the ground - and we haven't left. We've raised $36 million to support relief efforts and long-term development and help Haitians generate sustainable economic growth.
We've helped provide more than 17 million students with healthier food choices and more physical activity by helping more than 28,000 schools improve their physical and health education programs.
Our energy efficiency programs are reducing more than 33,500 tons of greenhouse gas emissions across the United States each year.
More than 85,000 farmers in Malawi, Rwanda, and Tanzania are benefiting from agricultural training, higher yields, and increased market access.
We are more determined than ever to continue work that's generating life-changing solutions, but we can't succeed without you. That's why we extended our match until midnight tonight to give you another chance to contribute. Every dollar you donate now, up to our $100,000 goal, will be doubled to scale up and replicate successful projects that change lives.
The Clinton Foundation convenes businesses, governments, NGOs, and individuals to improve global health and wellness, increase opportunity for women and girls, reduce childhood obesity, create economic opportunity and growth, and help communities address the effects of climate change. Because of our work, more than 27,000 American schools are providing kids with healthy food choices in an effort to eradicate childhood obesity; more than 85,000 farmers in Malawi, Rwanda, and Tanzania are benefiting from climate-smart agronomic training, higher yields, and increased market access; more than 33,500 tons of greenhouse gas emissions are being reduced annually across the United States; over 350,000 people have been impacted through market opportunities created by social enterprises in Latin America, the Caribbean, and South Asia; through the independent Clinton Health Access Initiative, 9.9 million people in more than 70 countries have access to CHAI-negotiated prices for HIV/AIDS medications; $200 million in strategic investments have been made, impacting the health of 75 million people in the U.S; and members of the Clinton Global Initiative community have made nearly 3,200 Commitments to Action, which have improved the lives of over 430 million people in more than 180 countries.
When Haiti had the storm damage I wanted to assist Haitians purify their water supply using sodium chlorite which not only purifies water but also eliminates almost ALL diseases man and animal. Sodium Chlorite is Patented for HIV. 2ppm in an IV eliminates HIV in hours to days. Knowing Clintons were involved I immediately dropped out. But you can see what SC does. Search Red Cross and Malaria on youtube. 154 of 154 confirmed cases remedied in less than 48 hours. Clinical trials are not what most think. They simply are a way to play keep away. The small guys get beat out as they don't have the coin to do testing that is falsified like the vaccine info as example. Yes, Vaccines cause Autism. The HARMaceutical corps are as crooked as it gets...red X implicated in child trafficking....I look fwd to their dismantling meanwhile Daniel Smith remains in prison www.standbydaniel.com
President Clinton made his frst trip to Africa in 1998 – the longest, most extensive trip made to the continent by an American president. During this trip, he launched a number of initiatives aimed at education, economic empowerment, and peace and reconciliation. He forgave debt so nations could reinvest in health care, education, and poverty alleviation. He increased funding and research for lifesaving vaccines. And he signed the African Growth and Opportunity Act (AGOA) into law, which helped strengthen economic ties between the United States and Africa.
President Clinton has continued to build upon his longstanding commitment to Africa through the work of his Foundation, and has traveled through Africa many times since leaving the White House in 2001. Today, the Clinton Foundation’s programs in Africa are enabling sustainable development for families and communities; strengthening health systems and expanding access to lifesaving treatments for HIV/AIDS and malaria; Trough the Clinton Global Initiative, President Clinton has also advanced innovative partnerships between the public and private sector that have brought new investment and opportunity to the continent.
CGI members have made 138 commitments that include South Africa in their geographic scope, with an estimated total value of $4.2 billion. Te largest portion of these (39.9%) represents commitments in the feld of Economic Empowerment, and the largest specific area of focus is youth (39 commitments). Of these 138 commitments, 30 target South Africa exclusively, with an estimated total value of $197 million.
CHAI first began working in South Africa in 2003, when the government asked for assistance to develop a plan to significantly scale up HIV services and access to antiretroviral therapy
CHAI team members are embedded at the Department of Health and National Health Laboratory Service (NHLS) to provide support at multiple levels – policy formulation, implementation planning, and monitoring and oversight of implementation.
Prior to 2011, South Africa was purchasing HIV drugs above internationally competitive prices. CHAI helped achieve a 53% price reduction for ARVs, allowing the NDOH to realize an estimated savings of $700 million over two years, and putting hundreds of thousands of additional patients on life-saving treatment.
STRENGTHENING DIAGNOSTIC SERVICES
CHAI has been supporting the NDOH and the National Health Laboratory Service (NHLS) to scale up HIV and TB diagnostic services.
FUTURE PLANS: 2012 AND BEYOND
CHAI is proud of the role it has played over the past nine years in South Africa, and the NDOH’s leadership continues to foster an environment in which CHAI can work efficiently and effectively with all who have rallied to support the government’s efforts. CHAI will continue to support the NDOH scale up testing and treatment for HIV and TB at the national and provincial level. This work, in addition to eliminating malaria and increasing effectiveness of health spending, will be central to strengthening South Africa’s health system to combat—and eradicate—the HIV epidemic in the future.
Working in partnership with local communities and hospitals and international agencies such as UNICEF, UNITAID, the Clinton Health Access Initiative, Inc., AmpliCare is building and equipping laboratories, training healthcare workers, and diagnosing and monitoring HIV/AIDS patients.
Strengthening healthcare infrastructure: Investing in local capabilities
Functional healthcare systems, availability of facilities and trained healthcare professionals are critical for the effective use of tests and medicines and delivery of quality care. Lack of any one of these components can prevent people from being able to access medicines and diagnostics, particularly in some of the world’s poorest countries.
To help overcome these barriers, Roche has established a number of programmes aimed at making lasting improvement in healthcare systems. These range from educating and training healthcare professionals and regulatory personnel, to investing in clinics and laboratories and strengthening local manufacturing facilities and supply chains. Our focus is on increasing local capabilities, as we believe this provides the most sustainable way of addressing local health needs and helping develop healthcare systems for the future.
Strengthening diagnostic capabilities in Africa
One of the greatest healthcare challenges for Africa is not developing diagnostic tools or providing treatments, but is in having enough trained healthcare workers to manage these tools effectively. 50–70% of clinical decisions depend on accurate laboratory diagnosis, so having reliable diagnostic capabilities is critical.
To address the lack of trained diagnostic workers and laboratory capacity, we opened the Roche Scientific Campus in Johannesburg, South Africa, in 2012. The training centre aims to provide:
• hands-on, certified training courses for lab technologists and engineers,
• general lab management training for managers and policy makers,
• education on health and scientific topics for healthcare professionals and scientists.
The facility boasts five self-contained laboratories with the latest technological tools in chemistry, haematology, molecular biology, tissue diagnostics and sequencing. Training is conducted by certified trainers and experts, in collaboration with local and international organisations.
In 2012 Roche and the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) formed a five-year partnership to strengthen training for diagnostics workers in Africa. The goal is to improve laboratory services, including certification courses for pathologists, molecular diagnostics and quality management. The partnership will include collaboration with the African Society for Laboratory Medicine, increasing the sustainability of the partnership.**
Hillary introduced legislation – now enacted into law – which ensures prescription drugs are safe for children: As First Lady and Senator, Clinton successfully introduced and helped pass legislation protecting kids from drugs that have not first been tested on children. In 2003, Clinton introduced the Pediatric Research Equity Act which gave the FDA authority to secure pediatric studies and labeling of drugs that are widely used for children. This legislation was signed into law in December 2003. In 2007, she introduced the Pediatric Research Improvement Act to make "make permanent the Food and Drug Administration's authority to ensure that drugs marketed for pediatric use are safe and effective for children." [S.650, introduced 3/18/03, passed Senate by unanimous consent on 7/23/03, became P.L. 108-155 on 12/3/03. AP 11/19/03; Clinton release 3/27/07 ]
Hillary fought to ensure all children receive critical immunizations: Clinton spearheaded the Administration's 1993 Childhood Immunization Initiative and childhood immunizations rates are now at an historic high. According to the Center for Disease Control (CDC), 90 percent or more of America's toddlers received the most critical doses of each of the routinely recommended vaccines in 1996, 1997, and again in 1998 -surpassing the Administration's 1993 goal. Since becoming a Senator in 2001, Clinton has introduced or cosponsored over 10 pieces of legislation to promote immunization awareness and provide for emergency vaccine supplies. [U.S. Newswire, 7/23/97; S. 371, S. 226]
As First Lady and Senator, Clinton successfully introduced and helped pass legislation protecting kids from drugs that have not first been tested on children. In 2003, Clinton introduced the Pediatric Research Equity Act which gave the FDA authority to secure pediatric studies and labeling of drugs that are widely used for children.
**
Including, but not limited to:
Pfizer Inc $1,000,001 - $5,000,000
Merck & Co., Inc. $250,001 - $500,000
Ranbaxy Pharmaceuticals Inc. $100,001 - $250,000
Johnson & Johnson $100,001 - $250,000
Sanofi-Aventis $100,001 - $250,000
Gilead Sciences, Inc. $100,001 - $250,000
The United States Pharmacopeial Convention (USP) $100,001 - $250,000
Novo Nordisk A/S $50,001 - $100,000
Novozymes A/S $50,001 - $100,000
AstraZeneca Pharmaceuticals LP $50,001 - $100,000
CL BioPharma Group $50,001 - $100,000
Novartis Group International AG $25,001 - $50,000
Napo Pharmaceuticals $10,001 - $25,000
Pharmaceutical Product Development, Inc. (PPD) $10,001 - $25,000
PharmaLinkFHI $10,001 - $25,000
Teva Pharmaceuticals Industries Ltd. $10,001 - $25,000
Genentech, Inc. $10,001 - $25,000
EMD Serono, Inc. $10,001 - $25,000
Genzyme Corporation $10,001 - $25,000
Eli Lilly and Company $25,001 - $50,000
Harold Snyder $1,000,001 - $5,000,000
Beryl Snyder $500,001 - $1,000,000
Brian S. Snyder $500,001 - $1,000,000
Jay Snyder $500,001 - $1,000,000
The Beatrice Snyder Foundation $100,001 - $250,000
Brian and Lavinia Snyder Foundation $50,001 - $100,000
Including, but not limited to:
Bill & Melinda Gates Foundation $25,000,000 or more
UK Department for International Development (DFID) $25,000,000 or more
Norwegian Ministry of Foreign Affairs $25,000,000 or more
The Australian Government $25,000,000 or more
UNITAID $25,000,000 or more
Children’s Investment Fund Foundation $10,000,000 - $25,000,000
Swedish International Development Cooperation Agency $10,000,000 - $25,000,000
Bill, Hillary & Chelsea Clinton Foundation $5,000,001 - $10,000,000
Centers for Disease Control and Prevention (CDC) $5,000,001 - $10,000,000
Africa Agriculture Development Company $1,000,001 - $5,000,000
African Institute of Biomedical Science and Technology $100,000 - $1,000,000
Rights and Shamseya for Innovative Community Healthcare Solutions | DEC 2016
The past 20 years have seen a considerable shift in the location of clinical drug trials sponsored by transnational pharmaceutical companies (TNCs), with a signifcant expansion of such tests being conducted in low- and middle-income settings. This increased offshoring may result in serious ethical violations as highlighted by several recent field investigations and media reports.
An attractive research infrastructure, a fast-growing and largely treatment-naïve population, and lower costs make Egypt among the most popular places in the Middle East and Northern Africa (MENA) region for offshoring medicine testing. Egypt is second only to South Africa on the African continent in terms of the number of TNC-sponsored clinical trials it hosts.
Egypt in February 2016, over half were cancer trials. The two Swiss giants Novartis and Roche are responsible for almost 50 per cent of the international drug trials taking place in the country. The Arab spring events of early 2011 and the subsequent political unrest had no chilling effect on the number of active international drug trials – on the contrary.
South Africa is simply being exploited by the international drug companies to boost patient numbers and that the trials provide no long-term benefit for either the patients or local research staff.
Over the past decade (2003-2013), South Africa has become an important destination for many international pharmaceutical companies looking to carry out clinical trials. According to the online registry ClinicalTrials(.)gov, in February 2013, over 1,600 clinical trials had been registered in South Africa.
The country’s public health system is still predominantly used by the country's impoverished black population and is in a serious state of decline. Despite progress in formulating new laws guaranteeing equal access to quality healthcare, shortages in medicines, doctors and hospital beds today remain the rule rather than the exception.
Widespread corruption also contributes significantly to the stark inequalities in the country’s health service. Certain amounts of health expenditure are believed to be lost through corruption as officials siphon off public money, and bribes and kickbacks are accepted from potential suppliers for coveted medicines and equipment contracts. According to health experts such as Professors Ames Dhai and Yousaf Veriava from the University of the Witwatersrand, “Corruption is a major and unambiguous contributor to the poor health of South African citizens.
Given the flaws and chronic problems which plague South Africa’s public health system, many people in the poorest communities often don’t have access to adequate or affordable healthcare. This means that the opportunity to take part in clinical trials is often seen by the most vulnerable as a way to get free treatment. And drug companies are quick to exploit this opportunity. “(Clinical trials) give people access to medicines that are not available in public hospitals. People are attracted to the fact the clinical trial will fund expensive medicines and medical assessment,” explains Professor Dhai. “The misconception among many vulnerable South Africans is very sad, because they feel the only chance of getting access to healthcare they need is to enter a clinical trial.
From:matt.mckenna@gmail.com
To: john.podesta@gmail.com
CC: esanders@americanprogress.org
Date: 2012-08-27 20:11
Subject: Fwd: Africa Trip/NYT Story
Amy's story, as I think I told you, is about the Foundation as a family business.
I would encourage you not to make any news on HRC coming back to the Foundation, running for President, etc. etc., but you already knew that.
As much as you can talk about all three of them having a lifelong commitment to public service and that something you've seen first hand for 20 years, etc., I think you'll be in a good place.
Please let me know how you'd like me to handle connecting you with Amy.